These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 9109227

  • 1. The role of surgery in the multimodality management of non-small cell lung cancer.
    Kaiser LR, Friedberg JS.
    Semin Thorac Cardiovasc Surg; 1997 Jan; 9(1):60-79. PubMed ID: 9109227
    [Abstract] [Full Text] [Related]

  • 2. [Multimodal treatment of non small cell lung cancer].
    Stoelben E, Digel W, Henke M, Passlick B.
    Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
    [Abstract] [Full Text] [Related]

  • 3. Is lobe-specific lymph node dissection appropriate in lung cancer patients undergoing routine mediastinoscopy?
    Turna A, Solak O, Kilicgun A, Metin M, Sayar A, Gürses A.
    Thorac Cardiovasc Surg; 2007 Mar; 55(2):112-9. PubMed ID: 17377865
    [Abstract] [Full Text] [Related]

  • 4. [Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis].
    Huang GJ, Fang DK, Cheng GY, Zhang DC.
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):62-4. PubMed ID: 16737625
    [Abstract] [Full Text] [Related]

  • 5. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.
    Lardinois D, Suter H, Hakki H, Rousson V, Betticher D, Ris HB.
    Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380
    [Abstract] [Full Text] [Related]

  • 6. The role of multimodality therapy in locoregional non-small cell lung cancer.
    Martini N, Kris MG, Ginsberg RJ.
    Surg Oncol Clin N Am; 1997 Oct; 6(4):769-91. PubMed ID: 9309093
    [Abstract] [Full Text] [Related]

  • 7. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y, Miyamoto H, Yamazaki A, Oh T, Fukai R, Shiomi K, Saito Y.
    Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
    [Abstract] [Full Text] [Related]

  • 8. Postrecurrence survival in patients with stage I non-small cell lung cancer.
    Nakagawa T, Okumura N, Ohata K, Igai H, Matsuoka T, Kameyama K.
    Eur J Cardiothorac Surg; 2008 Sep; 34(3):499-504. PubMed ID: 18579404
    [Abstract] [Full Text] [Related]

  • 9. Surgical assessment and intraoperative management of mediastinal lymph nodes in non-small cell lung cancer.
    Whitson BA, Groth SS, Maddaus MA.
    Ann Thorac Surg; 2007 Sep; 84(3):1059-65. PubMed ID: 17720443
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Value and limits of conventional mediastinoscopy in preoperative evaluation of primary bronchial cancer].
    Robert J, Rochat T, Savioz D, Ludwig C, Spiliopoulos A.
    Schweiz Med Wochenschr; 1998 Jun 06; 128(23):895-9. PubMed ID: 9658517
    [Abstract] [Full Text] [Related]

  • 12. Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer.
    Meyers BF, Haddad F, Siegel BA, Zoole JB, Battafarano RJ, Veeramachaneni N, Cooper JD, Patterson GA.
    J Thorac Cardiovasc Surg; 2006 Apr 06; 131(4):822-9; discussion 822-9. PubMed ID: 16580440
    [Abstract] [Full Text] [Related]

  • 13. Frequency of noncontiguous lymph node involvement in patients with resectable nonsmall cell lung carcinoma.
    Bonner JA, Garces YI, Sawyer TE, Gould PM, Foote RL, Deschamps C, Lange CM, Li H.
    Cancer; 1999 Oct 01; 86(7):1159-64. PubMed ID: 10506699
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
    Matsuguma H, Nakahara R, Ishikawa Y, Suzuki H, Inoue K, Katano S, Yokoi K.
    Interact Cardiovasc Thorac Surg; 2008 Aug 01; 7(4):573-7. PubMed ID: 18413349
    [Abstract] [Full Text] [Related]

  • 16. Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer.
    Cerfolio RJ, Bryant AS.
    Ann Thorac Surg; 2008 Aug 01; 86(2):362-6; discussion 366-7. PubMed ID: 18640297
    [Abstract] [Full Text] [Related]

  • 17. [State of the art treatment of lung cancer: non-small cell lung cancer--surgical treatment].
    Asamura H.
    Gan To Kagaku Ryoho; 1997 Oct 01; 24 Suppl 3():366-72. PubMed ID: 9369909
    [Abstract] [Full Text] [Related]

  • 18. [Local recurrence in complete resection for non-small cell lung cancer].
    Ohta S, Inaba H, Hirose M, Syundou Y.
    Kyobu Geka; 2000 Mar 01; 53(3):185-9. PubMed ID: 10714104
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Thoracoscopic lobectomy with systemic lymph node dissection for lymph node positive non-small cell lung cancer--is thoracoscopic lymph node dissection feasible?
    Shiraishi T, Hiratsuka M, Yoshinaga Y, Yamamoto S, Iwasaki A, Shirakusa T.
    Thorac Cardiovasc Surg; 2008 Apr 01; 56(3):162-6. PubMed ID: 18365976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.